← All Topics / ade

FDA ADE reports for Trilostane — total reports, species & reaction breakdown

ade_trilostane_adverse_events

ade 200 tok en 2026-07-22

Trilostane — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Trilostane is a veterinary active ingredient.

Total reports

Trilostane: 12001

Reports by species (top entries)

  • Dog 11720
  • Human 46
  • Cat 10
  • Horse 1
  • Other 1

Top reported reactions (VEDDRA terms, top entries)

  • Vomiting 1995
  • Lethargy (see also Central nervous system depression in 'Neurological') 1973
  • Hyperkalaemia 1742
  • Elevated serum alkaline phosphatase (SAP) 1687
  • Weight loss 1479
  • Underdose 1430
  • Diarrhoea 1425
  • Elevated alanine aminotransferase (ALT) 1372
  • Elevated blood urea nitrogen (BUN) 1121
  • Decreased appetite 1098

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22